Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.118.311963
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)